Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,381 | 57,263 | 80,927 | 178,266 | 305,744 |
| Receivables | 29,941 | 10,402 | 15,389 | 28,346 | 23,790 |
| Inventories | 9,624 | 14,431 | 10,206 | 14,159 | 9,862 |
| Other current assets | 0 | 1,165 | 0 | 0 | 0 |
| TOTAL | $123,841 | $90,371 | $117,022 | $230,432 | $346,462 |
| Non-Current Assets | |||||
| PPE Net | 2,519 | 3,260 | 6,505 | 13,020 | 15,066 |
| Investments And Advances | 17,660 | 2,585 | 0 | 0 | 0 |
| Intangibles | 27,605 | 31,863 | 20,287 | 27,197 | 12,552 |
| Other Non-Current Assets | 13,923 | 16,144 | 23,712 | 23,652 | 22,423 |
| TOTAL | $61,707 | $53,852 | $50,504 | $63,869 | $50,041 |
| Total Assets | $185,548 | $144,223 | $167,526 | $294,301 | $396,503 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,948 | 812 |
| Accounts payable and accrued liabilities | 47,125 | 65,501 | 73,562 | 97,446 | 90,660 |
| Other current liabilities | 136 | 1,718 | 4,980 | 16,917 | N/A |
| TOTAL | $49,744 | $71,399 | $84,908 | $127,715 | $101,042 |
| Non-Current Liabilities | |||||
| Long Term Debt | 52,417 | 57,962 | 60,856 | 93,142 | 46,564 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 2,611 |
| Other Non-Current Liabilities | 60,934 | 91,364 | 113,692 | 150,757 | 123,143 |
| TOTAL | $73,621 | $74,468 | $81,031 | $116,561 | $69,584 |
| Total Liabilities | $123,365 | $145,867 | $165,939 | $244,276 | $170,626 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,203 | 29,534 | 19,235 | 8,655 | 6,970 |
| Common Shares | 31 | 28 | 15 | 7 | 101 |
| Retained earnings | -734,052 | -740,867 | -694,870 | -634,233 | -547,463 |
| Other shareholders' equity | 12,310 | -24,381 | -20,957 | 8,304 | 117,203 |
| TOTAL | $62,183 | $-1,644 | $1,587 | $50,025 | $225,877 |
| Total Liabilities And Equity | $185,548 | $144,223 | $167,526 | $294,301 | $396,503 |